Chewy (CHWY) reached $22.97 at the closing of the latest trading day, reflecting a +1.64% change compared to its last close.
In the closing of the recent trading day, Chewy (CHWY) stood at $22.82, denoting a -2.06% move from the preceding trading day.
Chewy (CHWY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Chewy (CHWY) closed the most recent trading day at $20.86, moving +1.96% from the previous trading session.
In the latest trading session, Chewy (CHWY) closed at $20.46, marking a -4.93% move from the previous day.
Chewy (CHWY) closed the most recent trading day at $21.53, moving +1.51% from the previous trading session.
Recently, Zacks.com users have been paying close attention to Chewy (CHWY). This makes it worthwhile to examine what the stock has in store.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
CHWY is expanding its healthcare platform through Vet Care and Modern Animal to drive customer growth and long-term profitability.
Chewy remains a Strong Buy, with valuation implying a high margin of safety even under conservative assumptions and challenging macro conditions. Q1 delivered 7.7% YoY net sales growth, $71M FCF, record profitability, and nearly 200,000 net customer additions despite consumer headwinds. CHWY's guidance reflects macro pressure: net sales are expected at $13.40–$13.55B and Adj. EBITDA margin at 6.6–6.8%, but long-term potential remains intact.
Chewy is upgraded from Hold to Buy after a 40% stock decline and earnings multiple compression. CHWY's fundamentals have improved, with consistent top and bottom-line growth despite occasional estimate misses. The pet products market remains high-growth, supporting sustained demand and CHWY's upward business trajectory.
Chewy remains a "Buy" despite a ~40% YTD decline and a guidance cut, as I view challenges as cyclical, not structural. CHWY lowered FY26 sales outlook to $13.40–$13.55 billion, citing macro headwinds and consumer trade-down to lower-priced pet products. I see ongoing improvements in margins, customer net additions, and engagement, supporting long-term growth and share gains.